Tarantino P, Tayob N, Villacampa G, Dang C, et al. Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. J Clin Oncol 2024 Jun 27:JCO2302170. doi: 10.1200/JCO.23.02170.
PMID: 38935923